Keyword: BioNTech

BioNTech biotech investments

6. BioNTech

BioNTech earmarked its considerable series A round for the development of its clinical pipeline, which includes mRNA-based cancer vaccines, a CAR-T treatment and a T cell receptor therapy for various solid tumors.
Total annual biotech investments

Biotech's top 10 money raisers of 2018

Private biotechs raised a record-breaking $16.8 billion in 2018, blowing past the record $12.1 billion set the previous year. Here are the top 10 fundraising rounds—which broke some records themselves and together illustrate what's hot out there in the field.